arrow
S

Sebastian M. Meyhöfer

novonordisk
H指数:11
被引数:672

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Semaglutide对高危肝纤维化患者的肝纤维化和心脏结局的影响: 一项选择性随机试验的预设分析

2026-04-020
OAAI
Acute Cold Exposure Improves Glucose Tolerance and Induces Beta-Cell Secretion Response Linked to Lipid Utilization in Young Male with Obesity

急性冷暴露改善肥胖青年男性的葡萄糖耐受性,并诱导与脂质利用相关的β细胞分泌反应

2025-12-010
PRE
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding

PNPLA3 I148M变异与MASLD在空腹和进食状态下的不良代谢特征相关联。

2025-07-040
OA
The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes
2024-07-100
OAAI
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
2024-05-1331
OAAI
Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow-up registry
2022-12-202
PRE